some reason modern medicine has itself turned a corner and entered
a darkness and is now committing crimes against humanity unequalled
in the history of our race."
--Dr. Mark Sircus
Alternative Cancer Treatments
by DIANNE JACOBS THOMPSON (under
1979 Around January of that year, I went
home to die.
I was diagnosed with stage 2 stomach cancer, chronic bronchitis,
acutely infected ovarian cysts, arthritis, sciatica, low thyroid,
anemia and a heart condition. Besides that I had chronic ear infections
and long-standing clinical depression. The late Dr.
Harold Dick, N.D., known as a "naturopathic oncology pioneer"
cured me in 5 weeks. It required the diagnosis (the Carroll
Food Test) of digestive enzyme
deficiency food intolerances which most people have and few
know about, and it also identified the primary tissue
salt deficiency, along with treatment with glandular
protomorphogens to restore glandular health, and Constitutional
Hydrotherapy to bring about detoxification, to stimulate blood
circulation and the activity of the vital organs and to jump-start
the immune system. It turned out to be the basic foundation of the
most successful healing system I've ever witnessed.
1986 My 5-year-old daughter was forcibly vaccinated
and immediately developed a flesh-eating
infection so virulent that my husband and I became infected
from contact. Naturopathic medicine brought us back from the brink.
Later that year
we were introduced to escharotic
cancer salves and treated a dog tumor, my husband's cirrhosis
of the liver, various skin lesions, moles, fungal infections, and
a lump in my thigh. It eventually
helped clear up the remaining symptoms from my husband's flesh-eating
infection after he was forced to submit to antibiotic treatment
which made a mess of it. There was much more, gallbladder
problems in 1999, adrenal
deficiency 2001, injury in 2002, arthritis,
diabetes, and other issues between
2003-2012, including glaucoma--cured.
why I research and write about alternative medicine. It's a debt.
*Alternative treatments for cancer, chronic-degerative
disease, infection, stress, harmful emotions and other disorders and conditions;
junk science and bad medicine, including unsafe and ineffective vaccines
and undiagnosed medical conditions mimicking child abuse and Shaken Baby
site provides starting points. The rest of the journey must be yours.
"Truth wears no mask, seeks neither place nor
bows to no human shrine; she only asks a hearing"
CANCER CELL DEATH" --CHML TREATMENT
CHML Treatment-- "programmed cancer cell death."
A review from the
Eclectic Medicine International (EMI) staff at http://www.holisticcancersolutions.com/
"This is another breakthrough cancer therapy. It is very new, based
on recent biological discoveries. We have talked to patients whose inoperable
tumors were reduced 65-70% within a few weeks. According to the information
below, the treatment is non-toxic, benign, and very effective.
To eliminate every malignant cell, an anticancer drug must overcome
many formidable obstacles presented by a tumor mass.
The drug must travel
through the tumor’s intricate network of blood vessels
and disperse through the vessel walls into the interstitum – an
the tumor that is rich in a tough connective tissue protein called collagen.
From there, the drug must enter directly into cancer cells, which typically
occupy less than 50% of the total volume of a tumor.
cancer cell has an abundance of defense mechanisms to
block the full penetration of chemotherapeutic agents.
What makes CHML different,
is that its molecule is 33,000 times smaller
than normal cells, enabling it's penetration into the tumor mass. But
importantly, this facilitates its permeation directly into the cancer
Once it enters the cell, CHML is able to induce apoptosis (or "programmed
cancer cell death.").
Apoptosis programs cancer cells to commit suicide.
CHML has been called a biological, "cancer seeking missile".
It is patented
worldwide, and currently is under evaluation in the United States for
Over 500 patients received so far CHML treatments. Many of them were late
stage patients. Usually, these patients have exhausted a broad range of
conventional and/or alternative cancer treatments. Those with a history
of significant conventional intervention are normally the most difficult
to treat. However, even in these cases, CHML has been successful.
CHML treatment has been accompanied by virtually none of the side effects
commonly associated with cancer chemotherapy.
CHML may be administered
by: IV drip, local injection, or by a sophisticated
new technology which allows area-specific, concentrated drug delivery.
DSA (Digital Subtraction Angiography), CHML is delivered directly to a
of major concern by Arterial Infusion.
Used regularly in
Cardiology practice, this technology is capable of delivering
concurrent imaging of the intricate blood vessel network of a tumor. DSA
used to guide the delivery of CHML, as well as measure the immediate effects
on the tumors blood supply network.
"Working to provide restored health and a new future -
for individuals dealing with a terminal diagnoses. . ."
Cell death was once thought to be a passive non-specific event, but is
now known to be an active biochemical process. Scientists have discovered
that any cells have the ability to die by this process, called programmed
cell death or apoptosis.
A number of important
human diseases are caused by abnormal apoptosis control mechanisms, which
can result in either a pathological increase in the number of cells (e.g.
cancer) or a damaging loss of cells (e.g. degenerative diseases). Recent
data has shown that cells have a discrete cell death pathway defined by
a specific set of genes. These genes encode proteins that form the biochemical
process that ultimately invokes cell death.
The key genes that
control the cell death process are the cell death effectors of the CED-3/ICE
("caspase") family and the cell death inhibitors of the Bcl-2
family. The caspase gene family encodes a set of proteases responsible
for carrying out the death process. In a living cell, these proteases
are normally kept inactive by proteins encoded by the Bcl-2 family.
Small molecule drugs,
like CHML, are able to specifically modulate the activity of the caspase
family, the Bcl-2 family, or other key points in the apoptotic pathway,
and exert control over the cell death process and have utility in diseases
characterized by either excessive or insufficient levels of apoptosis.
The caspases are a
family of proteases responsible for carrying out the cell death process.
In a living cell, these proteases are kept inactive by proteins on the
mitochondrial cell surface from the BcL-2 family. When a cell is exposed
to cell death signals such as ischemia, chemotherapy or radiation, BcL-2
function is blocked and caspase activators initiate the cell death cascade.
CHML is able to specifically
modulate key points in the apoptotic pathway.
p53 protein, commonly referred to as "the tumor suppressor gene,"
is a key player in the cellular apoptosis process. Bio-therapeutic activation
of this pathway has been a popular target for recent drug discovery technology.
p53, Bax and p21 protein
levels were measured by immunoblotting assay, in MCF-7, ML-1, H1299 (human
lung carcinoma) and RKO (human colon cancer,) cell lines after treatment
with CHML. p53 protein was found to be elevated in the MCF-7, RKO and
As the ability to
induce apoptosis is not limited to p53 positive cell lines, it appears
that CHML is able to provoke apoptosis through both p53-dependant and
Supporting GLORY's drug discovery program, is a sophisticated new technology
for drug administration. Arterial Infusion using DSA is a fast developing
science, administered by trained Interventional Radiologists. Formerly
used in the management of Cardiology related conditions, the technology
is capable of delivering concentrated drugs to a highly specific site
(e.g. tumor,) via the arterial network.
DSA is capable of delivering concurrent imaging of the intricate vasculature
of the tumoral network. This is used to guide the delivery of CHML, as
well as measure the immediate effects on the tumor's blood supply network.
In recent studies,
CHML was able to effect significant disruptions to the tumoral vasculature
network in a number of various malignancies. In virtually every case,
marked destruction of the tumor's feeding system could be observed in
less than 30 minutes.
These data provide
further corroboration of CHML's ability to penetrate a number of difficult
The CHML treatment
is available in an offshore clinic.
The present cost of the full treatment, that lasts one to three months,
is approx. $25,000.
For Information contact:
Sean A. Cohen,
11500 Silvergate Dr.
Dublin, CA 94568-2707
Phone: (925) 828-5093
Send mail to:
International Business Offices
4020 Washington Blvd, Suite 309
Arlington, VA 22201
Phone: (703) 204-2657
Fax: (703) 204-2658
Thompson Est. 2003
The Misdiagnosis of
"Shaken Baby Syndrome" --an unproven theory without scientific
support, now in disrepute and wreaking legal and medical havoc world-wide
Author publication: NEXUS MAGAZINE "Seawater--A
Safe Blood Plasma Substitute?"
The material on this site is for informational and educational
purposes only. Please consult with your health care provider for treatment
Fight Spam! Click Here!